Results of the phase III trials with Imagent GI as an oral magnetic resonance contrast agent.
Mattrey
R F
RF
University of California, San Diego.
Trambert
M A
MA
Brown
J J
JJ
Bruneton
J N
JN
Young
S W
SW
Schooley
G L
GL
D000284:Administration, Oral; D000328:Adult; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000008:administration & dosage; D004655:Emulsions; D005466:Fluorocarbons / Q000008:administration & dosage; D005767:Gastrointestinal Diseases / Q000175:diagnosis*; D006801:Humans; D006842:Hydrocarbons, Brominated; D008279:Magnetic Resonance Imaging / Q000379:methods*
D003287:Contrast Media; D004655:Emulsions; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; C003072:perflubron